
Udai Kammula
Director, Solid Tumor Cell Therapy Program, UPMC Hillman Cancer Center · UPMC Medical Education
Credentials: · · · ·
History
Research
Cancer regression in patients after transfer of genetically engineered lymphocytes
Science · 2006 · 2,082 citations
Clinical Cancer Research · 2011 · 1,726 citations
Journal of Clinical Oncology · 2011 · 1,323 citations

54 papers · 12 as a fellow

40 papers

29 papers · 2 as a fellow

19 papers
- JW
17 papers
- GP
13 papers
- FM
12 papers

12 papers · 4 as a resident
Grants
- 2006–2029
Postdoctoral Research Training in Biotherapy of Cancer
National Cancer Institute · T32
Contact PI · $1.7M · University of Pittsburgh at Pittsburgh
- 2019–2024
Metabolic Reprogramming of Tumor Infiltrating Lymphocytes for Adoptive Immunotherapy
National Cancer Institute · R01
Contact PI · $1.8M · University of Pittsburgh at Pittsburgh
High Throughput Isolation of Antigen Specific T-Cells for Cancer Therapy
National Cancer Institute · ZIA
Contact PI · $5.5M · Division of Basic Sciences - Nci
Immunotherapy Strategies for Uveal Melanoma
National Cancer Institute · ZIA
Contact PI · $3.7M · Division of Basic Sciences - Nci
Clinical trials
- 2019–2038
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
Principal investigator · Active not recruiting · Phase 2
Udai Kammula
- 2019–2031
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
Principal investigator · Active not recruiting · Phase 2
Udai Kammula
- 2018–2027
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
Principal investigator · Active not recruiting · Phase 2
Udai Kammula
- 2011–2014
Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor Cells
Principal investigator · Terminated · Phase 2
National Cancer Institute (NCI)



